141 related articles for article (PubMed ID: 7545214)
1. Treatment of chronic hepatitis C with cirrhosis with recombinant human granulocyte colony-stimulating factor plus recombinant interferon-alpha.
Pardo M; Castillo I; Navas S; Carreño V
J Med Virol; 1995 Apr; 45(4):439-44. PubMed ID: 7545214
[TBL] [Abstract][Full Text] [Related]
2. Re-treatment of interferon-resistant patients with chronic hepatitis C with interferon-alpha.
Bresci G; Parisi G; Banti S; Capzia A
J Viral Hepat; 1995; 2(3):155-8. PubMed ID: 7493311
[TBL] [Abstract][Full Text] [Related]
3. Treatment with recombinant alpha-interferon of chronic hepatitis C in anti-HIV-positive patients.
Marriott E; Navas S; del Romero J; García S; Castillo I; Quiroga JA; Carreño V
J Med Virol; 1993 Jun; 40(2):107-11. PubMed ID: 8395552
[TBL] [Abstract][Full Text] [Related]
4. Clinical predictors of response to recombinant interferon-alpha treatment in patients with chronic non-A, non-B hepatitis (hepatitis C). The Hepatitis Interventional Therapy Group.
Davis GL; Lindsay K; Albrecht J; Bodenheimer HC; Balart LA; Perrillo RP; Dienstag JL; Tamburro C; Schiff ER; Carey W
J Viral Hepat; 1994; 1(1):55-63. PubMed ID: 8790560
[TBL] [Abstract][Full Text] [Related]
5. Use of granulocyte macrophage colony stimulating factor alone or in combination with interferon-alpha-2b for treatment of chronic hepatitis C.
Shiffman ML; Hofmann CM; Luketic VA; Sanyal AJ
J Hepatol; 1998 Mar; 28(3):382-9. PubMed ID: 9551674
[TBL] [Abstract][Full Text] [Related]
6. Treatment of children with chronic hepatitis C with recombinant interferon-alpha: a pilot study.
Ruiz-Moreno M; Rua MJ; Castillo I; García-Novo MD; Santos M; Navas S; Carreño V
Hepatology; 1992 Oct; 16(4):882-5. PubMed ID: 1328009
[TBL] [Abstract][Full Text] [Related]
7. Combination treatment of advanced HCV associated liver disease with interferon and G-CSF.
Van Thiel DH; Faruki H; Friedlander L; Fagiuoli S; Caraceni P; Molloy PJ; Kania RJ; Wright HI
Hepatogastroenterology; 1995; 42(6):907-12. PubMed ID: 8847044
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover.
Zeuzem S; Schmidt JM; Lee JH; von Wagner M; Teuber G; Roth WK
Hepatology; 1998 Jul; 28(1):245-52. PubMed ID: 9657119
[TBL] [Abstract][Full Text] [Related]
9. Dose increase augments response rate to interferon-alpha in chronic hepatitis C.
Ferenci P; Stauber R; Propst A; Fiedler R; Müller C; Gschwantler M; Schütze K; Datz C; Judmaier G; Vogel W; Krejs GJ; Gangl A
Dig Dis Sci; 1996 Dec; 41(12 Suppl):103S-108S. PubMed ID: 9011466
[TBL] [Abstract][Full Text] [Related]
10. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.
Glaspy JA; Souza L; Scates S; Narachi M; Blatt L; Ambersley J; Golde DW
J Immunother (1991); 1992 Apr; 11(3):198-208. PubMed ID: 1381218
[TBL] [Abstract][Full Text] [Related]
11. Pilot study of recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of chronic hepatitis B.
Martin J; Bosch O; Moraleda G; Bartolome J; Quiroga JA; Carreño V
Hepatology; 1993 Oct; 18(4):775-80. PubMed ID: 8406350
[TBL] [Abstract][Full Text] [Related]
12. Interferon alfa-2b alone or combined with recombinant granulocyte-macrophage colony-stimulating factor as treatment of chronic hepatitis C.
Grønbaek K; Krarup HB; Ring-Larsen H; Schaffalitzky de Muckadell O; Møller A; Schlichting P; Vyberg M
Scand J Gastroenterol; 2002 Jul; 37(7):840-4. PubMed ID: 12190100
[TBL] [Abstract][Full Text] [Related]
13. [Effect of recombinant human granulocyte colony stimulating factor (rhG-CSF) in patients receiving chemotherapy--phase I study].
Fukutani H; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Nagamine D; Shinagawa K; Tabata M; Hirano A; Mizunuma N
Gan To Kagaku Ryoho; 1989 May; 16(5):2005-12. PubMed ID: 2471461
[TBL] [Abstract][Full Text] [Related]
14. Prolonged treatment (2 years) with different doses (3 versus 6 MU) of interferon alpha-2b for chronic hepatitis type C. Results of a multicenter randomized trial.
Saracco G; Borghesio E; Mesina P; Solinas A; Spezia C; Macor F; Gallo V; Chiandussi L; Donada C; Donadon V; Spirito F; Mangia A; Andriulli A; Verme G; Rizzetto M
J Hepatol; 1997 Jul; 27(1):56-62. PubMed ID: 9252074
[TBL] [Abstract][Full Text] [Related]
15. High-dose interferon-alpha2b treatment prevents chronicity in acute hepatitis C: a pilot study.
Vogel W; Graziadei I; Umlauft F; Datz C; Hackl F; Allinger S; Grünewald K; Patsch J
Dig Dis Sci; 1996 Dec; 41(12 Suppl):81S-85S. PubMed ID: 9011481
[TBL] [Abstract][Full Text] [Related]
16. Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C: a randomized multicenter trial. Hepatitis Interventional Therapy Group.
Lindsay KL; Davis GL; Schiff ER; Bodenheimer HC; Balart LA; Dienstag JL; Perrillo RP; Tamburro CH; Goff JS; Everson GT; Silva M; Katkov WN; Goodman Z; Lau JY; Maertens G; Gogate J; Sanghvi B; Albrecht J
Hepatology; 1996 Nov; 24(5):1034-40. PubMed ID: 8903371
[TBL] [Abstract][Full Text] [Related]
17. High sustained response rate and clearance of viremia in chronic hepatitis C after treatment with interferon-alpha 2b for 60 weeks.
Reichard O; Foberg U; Frydén A; Mattsson L; Norkrans G; Sönnerborg A; Wejstål R; Yun ZB; Weiland O
Hepatology; 1994 Feb; 19(2):280-5. PubMed ID: 7507462
[TBL] [Abstract][Full Text] [Related]
18. Treatment of chronic hepatitis C by continuous subcutaneous infusion of interferon-alpha.
Carreño V; Tapia L; Ryff JC; Quiroga JA; Castillo I
J Med Virol; 1992 Jul; 37(3):215-9. PubMed ID: 1331310
[TBL] [Abstract][Full Text] [Related]
19. A study of dose escalation of teniposide (VM-26) plus cisplatin (CDDP) with recombinant human granulocyte colony-stimulating factor (rhG-CSF) in patients with advanced small cell lung cancer.
Eguchi K; Etou H; Miyachi S; Morinari H; Nakada K; Noda K; Ohkuni Y; Watanabe K; Yamada Y; Ohe Y
Eur J Cancer; 1994; 30A(2):188-94. PubMed ID: 7512356
[TBL] [Abstract][Full Text] [Related]
20. [Recombinant interferon alfa in the treatment of chronic hepatitis C].
Coelho HS; Soares JA; Carvalho BB; Santos MA; Soldan M
Rev Assoc Med Bras (1992); 1995; 41(5):313-7. PubMed ID: 8731593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
